Sinorda and WuXi Partner on Bispecific Antibody Development and Manufacturing

Sinorda has completed in vitro functional validation studies of SND006 and plans to submit IND applications to the National Medical Products Administration (NMPA) in China and the FDA this year. The post Sinorda and WuXi Partner on Bispecific Antibody Development and Manufacturing appeared first on GEN - Genetic Engineering and Biotechnology News.